Vidaza and disease progression Patient Reports February 11, 2012

Vidaza Side Effects Report #4867502-5
Vidaza side effect was reported by a Physician from UNITED STATES on Dec 19, 2005. Male patient, 90 years of age, weighting 200.0 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: disease progression, injection site erythema, injection site vesicles, myelodysplastic syndrome. Vidaza dosage: 100 MG, DAILY X 5 DAYS, SUBCUTANEOUS. During the same period patient was treated with ARANESP. Patient was hospitalized. Patient died on 11/02/2005.

Vidaza Side Effects Report #5738425-4
Vidaza side effect was reported by a Physician from UNITED STATES on Apr 30, 2008. Male patient, 75 years of age, weighting 218.3 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: cardiac failure congestive, disease progression, hilar lymphadenopathy, lymphadenopathy mediastinal, pharyngitis streptococcal, prothrombin time prolonged, pulmonary embolism . Vidaza dosage: 75 MG/M2, DAILY X 5,SUBCUTANEOUS. During the same period patient was treated with OXYCODONE, CARTIA XT, HYDRALAZINE, ANAGRELIDE, LASIX, COUMADIN, POTASSIUM, VITAMIN B12. Patient was hospitalized. Patient recovered.

Vidaza Side Effects Report #4831467-2
Vidaza side effect was reported by a Physician from UNITED STATES on Nov 01, 2005. Male patient, 75 years of age, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, disease progression, nausea , refractory anaemia. Vidaza dosage: 75 MG/M2 (DAILY X 7 DAYS, EVERY 28 DAYS). During the same period patient was treated with TAMSULOSIN. Patient recovered.

Vidaza Side Effects Report #4648980-3
Vidaza side effect was reported by a Physician from on Apr 12, 2005. Male patient, 68 years of age, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: disease progression, febrile neutropenia. Vidaza dosage: unknown. During the same period patient was treated with THALOMID. Patient died on 11/27/2004.


Vidaza Side Effects Report #5874911-4
Vidaza side effect was reported by a Health Professional from AUSTRALIA on Aug 19, 2008. Male patient, 64 years of age, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: atrophy, brain scan abnormal, circulatory collapse, disease progression, loss of consciousness. Vidaza dosage: (77 MG/M2, DAILY X7 DAYS) ,SUBCUTANEOUS. During the same period patient was treated with THALIDOMIDE, SERETIDE, COLOXYL, SENNA. Patient was hospitalized. Patient recovered.

Vidaza Side Effects Report #5902869-8
Vidaza side effect was reported by a Physician from AUSTRALIA on Sept 15, 2008. Female patient, 54 years of age, weighting 94.80 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: acute pulmonary oedema, disease progression, dyspnoea, leukocytosis. Vidaza dosage: 76 MG/M2,X7 DAY, SUBCUTANEOUS. During the same period patient was treated with THALIDOMIDE. Patient was hospitalized. Patient recovered.

Vidaza Side Effects Report #5912095-4
Vidaza side effect was reported by a Physician from AUSTRALIA on Sept 24, 2008. Female patient, 54 years of age, weighting 94.80 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: acute pulmonary oedema, disease progression, escherichia sepsis, leukocytosis. Vidaza dosage: (76 MG/M2, X 7 DAY), SUBCUTANEOUS. During the same period patient was treated with THALIDOMIDE. Patient was hospitalized. Patient died on 09/20/2008.

Vidaza Side Effects Report #5178225-X
Vidaza side effect was reported by a Physician from PHILIPPINES on Nov 23, 2006. Male patient was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: disease progression. Vidaza dosage: 100 MG (DAILY X 7 DAYS), SUBCUTANEOUS. Patient died.

Vidaza Side Effects Report #5237948-4
Vidaza side effect was reported by a Physician from PHILIPPINES on Feb 01, 2007. Female patient, 54 years of age, was diagnosed with acute myeloid leukaemia and was treated with Vidaza. After drug was administered, patient experienced the following side effects: anaemia, arrhythmia , asthenia, disease progression, platelet count decreased. Vidaza dosage: 50 MG/M2 (DAILY X 7 DAYS), SUBCUTANEOUS. During the same period patient was treated with NASEA, DEPAKOTE. Patient died on 01/18/2007.


Vidaza Side Effects Report #6105709-X
Vidaza side effect was reported by a Health Professional from UNITED STATES on Mar 04, 2009. Female patient, 50 years of age, weighting 224.9 lb, was treated with Vidaza. After drug was administered, patient experienced the following side effects: disease progression, hypercalcaemia, mental status changes, motor dysfunction, speech disorder. Vidaza dosage: unknown. During the same period patient was treated with TARCEVA. Patient died on 02/27/2009.